The SYNGO project, a joint initiative of CNCR (MCN, FGA), The Broad Institute/Stanley Center in Cambridge, USA and the GO-consortium, announced reaching their phase II targets towards the evidence-based annotation of synaptic genes.
At their joint meeting at the McGovern Center in Cambridge on Sept 23rd 2017, the SYNGO consortium announced they have reached their 2017 target of 1000 literature-curated annotations of synaptic genes. Synapse biologists from expert labs in the US, Canada, Asia and Europe came together with bioinformaticians of the GO-consortium and CNCR, Amsterdam, to make final decisions on Biological Process (BP) and Cellular Component (CC) models, two of the cornerstones of GO-framework annotation. The time line was set for the next few months in preparation for SynGO to go public!
Eleven expert labs reflected on their experience with the current SynGO platform and annotation interface and provided valuable suggestions for future development of SynGO. In particular the computational and visualization tools for the upcoming SynGO platform empowering the wider scientific community were discussed.
The SynGO projected was presented at the Stanley Center meeting “severe mental illness: from genes to models to mechanisms”, held Sept 24-25, and warmly received by the community.
The Stanley Center leadership (profs. Guoping Feng and Steve Hyman) announced their continued support for this project in the coming years.